These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33089149)

  • 1. Evolving trends in pancreatic cancer therapeutic development.
    Bijou I; Wang J
    Ann Pancreat Cancer; 2019 Oct; 2():. PubMed ID: 33089149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine.
    Hegde S
    Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):118-127. PubMed ID: 33994737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic developments in pancreatic cancer: current and future perspectives.
    Neoptolemos JP; Kleeff J; Michl P; Costello E; Greenhalf W; Palmer DH
    Nat Rev Gastroenterol Hepatol; 2018 Jun; 15(6):333-348. PubMed ID: 29717230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer.
    Liu X; Li Z; Wang Y
    Adv Biol (Weinh); 2021 Mar; 5(3):e1900236. PubMed ID: 33729700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
    O'Hayer KM; Brody JR
    Discov Med; 2016 Feb; 21(114):117-23. PubMed ID: 27011047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: challenges and opportunities.
    Zhu H; Li T; Du Y; Li M
    BMC Med; 2018 Nov; 16(1):214. PubMed ID: 30463539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.
    Tesfaye AA; Kamgar M; Azmi A; Philip PA
    Expert Rev Anticancer Ther; 2018 Feb; 18(2):131-148. PubMed ID: 29254387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine.
    Ayasun R; Saridogan T; Gaber O; Sahin IH
    Clin Colorectal Cancer; 2023 Mar; 22(1):2-11. PubMed ID: 36418197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.
    Chiorean EG; Coveler AL
    Drug Des Devel Ther; 2015; 9():3529-45. PubMed ID: 26185420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on treatment options for pancreatic adenocarcinoma.
    Lambert A; Schwarz L; Borbath I; Henry A; Van Laethem JL; Malka D; Ducreux M; Conroy T
    Ther Adv Med Oncol; 2019; 11():1758835919875568. PubMed ID: 31598142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A narrative review of the evolving landscape of the management of metastatic gastric cancer: the role of targeted therapies.
    Delgado-Ramos GM; Fitzsimons J; Dhanarajan A
    J Gastrointest Oncol; 2023 Dec; 14(6):2600-2616. PubMed ID: 38196524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances and Future Challenges in Pancreatic Cancer Care: Early Detection, Liquid Biopsies, Precision Medicine and Artificial Intelligence.
    Daamen LA; Molenaar IQ; Groot VP
    J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for the management of pancreatic cancer.
    Rossi ML; Rehman AA; Gondi CS
    World J Gastroenterol; 2014 Aug; 20(32):11142-59. PubMed ID: 25170201
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.